|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 39/395 | (2013.01) | ||
| C07K 16/18 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61K 38/00 | (2013.01) | ||
| C12N 15/09 | (2006.01) | ||
| C07K 16/2818 | (2013.01) | ||
| C07K2317/24 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| C07K2317/92 | (2013.01) | ||
| C07K2319/30 | (2013.01) | ||
| A61K 39/001129 | (2018.08) | ||
| A61K 39/001111 | (2018.08) |
| (11) | Patento numeris | 3503920 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17844198.6 |
| Europos patento paraiškos padavimo data | 2017-08-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-07-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-05-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/047721 |
| Data | 2017-08-21 |
| (87) | Numeris | WO 2018/039097 |
| Data | 2018-03-01 |
| (30) | Numeris | Data | Šalis |
| PCT/CN2016/096357 | 2016-08-23 | WO |
| (72) |
LI, Baiyong , CN
XIA, Yu , CN
ZHANG, Peng , CN
PANG, Xinghua , CN
WANG, Zhongmin , CN
|
| (73) |
Akeso Biopharma, Inc. ,
6 Shennong Road
Torch Development Zone, Zhongshan, Guangdong 528437,
CN
|
| (54) | ANTI-CTLA4 ANTIBODIES |
| ANTI-CTLA4 ANTIBODIES |